STOCK TITAN

AbbVie Inc. reported $61.2B in revenue and $4.2B in net income for fiscal 2025. See the full ABBV financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

AbbVie will webcast a management fireside chat from the Morgan Stanley Global Healthcare Conference, with live and archived access for investors.

(Neutral)
Tags

AbbVie (ABBV) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, including a management fireside chat.

The discussion is scheduled for 9:00 a.m. Central time and will be available via live audio webcast on AbbVie’s Investor Relations website, with an archived replay accessible later that day.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NORTH CHICAGO, Ill., Sept. 3, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026. Management will participate in a fireside chat at 9:00 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media:

Catherine Langel   
(708) 508-3524
catherine.langel@abbvie.com

Investors:

Liz Shea
(847) 935-2211

liz.shea@abbvie.com

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302868211.html

SOURCE AbbVie

FAQ

When will AbbVie (ABBV) present at the Morgan Stanley 24th Annual Global Healthcare Conference?

AbbVie will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026. Management is scheduled for a fireside chat that morning, which will be accessible to investors via webcast.

What time is AbbVie’s fireside chat at the Morgan Stanley healthcare conference and in which time zone?

AbbVie’s management will participate in a fireside chat at 9:00 a.m. Central time on September 15, 2026. The session will be part of the Morgan Stanley 24th Annual Global Healthcare Conference program.

How can investors listen to AbbVie’s presentation at the Morgan Stanley Global Healthcare Conference?

Investors can access a live audio webcast of AbbVie’s presentation through the company’s Investor Relations website at investors.abbvie.com. An archived edition of the session will also be available on the site later the same day.